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ABSTRACT
The Materials Dispersion and Biodynamics Project (MDBP) focuses on dispersion and mixing of
various biological materials and the dynamics of cell-to-cell communication and intracellular
molecular trafficking in microgravity. Research activities encompass biomedical applications, basic
cell biology, biotechnology (products from cells), protein crystal development, ecological life
support systems (involving algae and bacteria), drug delivery (microencapsulation), biofilm depo-
sition by living organisms and hardware development to support living cells on Space Station
Freedom (SSF).
Project goals are to expand the existing microgravity science database through experiments on
sounding rockets, the Shuttle and COMET program orbiters and to evolve, through current database
acquisition and feasibility testing, to more mature and larger-scale commercial operations on SSF.
Maximized utilization of SSF for these science applications will mean that service companies will
have a role in providing equipment for use by a number of different custorners. An example of a
potential forerunner of such a service for SSF is the Materials Dispersion Apparatus (MDA)
"minilab" of Instrumentation Technology Associates, Inc. (ITA) in use on the ShuttIe for the
Commercial MDAITA Experiments (CMIX) Project. The MDA wells provide the capability for a
number of investigators to perform mixing and bioprocessing experiments in space. In the area of
human adaptation to microgravity, a significant database has been obtained over the past three
decades. Some Iow-g effects are similar to Earth-based disorders (anemia, osteoporosis, neuromus-
cular diseases and immune system disorders). Spending in the area of Earth-based biopharmaceuticals
is increasing and is projected to be in the range of $60 billion by the end of this decade, 50 times
greater than it is now (Burill, G.S. and Lee, K.B. 1991. Biotech 91: A Changing Environment, Ernst
and Young, San Francisco, CA). As new information targets potential profit-making processes,
services and products from microgravity, commercial space ventures are expected to expand
accordingly. Cooperative CCDS research in the above mentioned areas is essential for maturing SSF
biotechnology and to ensure U.S. leadership in space technology.
Currently, the MDBP conducts collaborative research with investigators at the Rockefeller Univer-
sity, National Cancer Institute, and the Universities of California, Arizona and Alabama in
Birmingham. The growing database from these collaborations provides fundamental information
applicable to development of cell products, manipulation of immune cell response, bone cell growth
and mineralization and other processes altered by low-gravity. Contacts with biotechnology and
biopharmaceutical companies are being increased to reach uninformed potential SSF users, provide
access through the CMDS to interested users for feasibility studies and to continue active involve-
ment of current participants. We encourage and actively seek participation of private sector
companies, and university and government researchers interested in biopharmaceuticals, hardware
development and fundamental research inmicrogravity. The project has two industry participants at
present. These are Instrumentation Technology Associates, Inc. (ITA), Exton PA (hardware
provider) and RANTEK, a biomedical R & D company with headquarters in Florida and offices in
Huntsville.
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The challenge of new ventures such as SSF, man's presence on the Moon, Mars and beyond, can be
met enthusiastically with the philosophy stated by Werher von Buaun: "The value of discovery
becomes clear only in the wake of the discovery itself. No one can imagine what may accrue to
mankind from the space program any more than Isabella could imagine what would come of
Columbus' voyages." The development of bio-processes and biopharmaceuticals in space leading
to enhanced quality of life on Earth, ameliorating undesirable space effects and contributing to US
leadership in the world economy is a reasonable expectation.
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MATERIALS DISPERSION AND BIODYNAMICS
PROJECT FOCUS
0 Materials dispersion and mixing in microgravity
o Fluids and particles
o Liquid/liquid
0 Dynamics of biological systems
o Cell-to-cell communication
o Intracellular molecular trafficking
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ACTIVITIES
ACTIVITIES ENCOMPASS SEVERAL BROAD DISCIPLINES.
o Biomedical
o Basic cell biology
o Biotechnology (products from cells)
o Protein crystal development
o Life support (algae and bacteria)
o Drug delivery (microencapsulation)
o Hardware development for cellular life
support
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PROJECT OBJECTIVES
To create private sector awareness
potential in the space environment.
of R & D
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To facilitate private sector company growth in the
areas of:
Services: hardware for Iow-g research
Products: (cells, cell products, crystals)
Processes: (ways to achieve products from Iow-g research)
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TIlE COMMERCIAL MDA |TA EXrERIMENTS (CMIX) PROGRAM
O Y_F,RYl F,__
0 Created by - Agreement hetween NASA, Office of Couuuercial Programs and UAII.
Purpose - To provide additional research opportunities ml tile Space Shuttle ror
NASA's 17 CCDS's.
Program managed by the UAII CMI)S
0 I)urathm of Agreemenl - 5-year period or until 5 nights are accomplished.
0 First Illghl scheduled for Seplember 1992
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PROJECT GOALS
To expand the knowledge gained in the past
three decades of microgravity research.
o Historic - effects of low-gravity on
human physiology
o Recent and ongoing - low-gravity
effects on single cells
To apply this information to develop SSF
experiments and utilization in the areas of:
o Commercialization
o Basic science
583
EFFECTS OF LOW-GRAVITY
PHYSIOLOGY
ON HUM(_
_S_QMELOW-G EFFECTS CORRESPONDING EARTH-BASED DISORDER
Bone demineralization Osteoporosis due to aging
Immune response blunted Immune deficiency, leukemias
Cardiac deconditioning Hypertension, heart failure
Muscle deconditioning Muscle wasting diseases
Decreased red blood cell count Anemia
To E NSURE SAFETY AND MAXIMIZE PRODUCTIVITY OF
HUMANS IN SPACEy CONTINUOUS RESEARCH IS NEEDED IN
THE FOLLOWING AREAS:
Cellular differentiation (i.e. stem cells to RBC's)
Interactions of cells with drugs and medications in microgravity
Remediation of bone mineral loss and reduced bone cell growth
Mechanisms of reduced immune cell response and selective
immunotherapy
Mechanisms of virus infectivity in microgravity (cell receptors/cell
mediated immunity)
Nerve cell responses to stimuli (intracellular mechanisms)
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MICROGRAVITY EFFECTS AT THE CELLULAR
LEVEL
PROCESS ALTERED EFFECT OF SPACEFLIGHT
Gene expression Suppression of some types
Cellular metabolism Glucose use rate lowered
Secretory processes Decreased or increased - cell type
T-lymphocytes Reactivity suppressed
Plant cell metabolism Fatty acid content shifts
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MEDICAL/BIOLOGICAL UTILIZATION OF SSF
O SSF long-term, continuous Iwo-g environment
can provide research capability to determine
o Cellular mechanisms
o Develop remedies
O Resulting in
o Spinning off new technologies
o Development of new biopharmaceuticals
o Advanced knowledge of fundamental biological
processes.
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POTENTIAL AREAS OF MEDICAL
APPLICATION
potential Markets
Companies producing natural cell products
cancer
Institutions supplying cells
Biodynamic cell culture
Biodeposition (mammalian cells)
Pharmaceutical
COMMERCIAL
Application
Infectious disease,
Transplantation
Cellular and tissue
development
Osteoporos is/bone
regeneration
Liposome and drug
delivery technology
Pharmaceutical Protein crystals,
drug design
BENEFITS FROM SSF RESEARCH_
IMPROVED QUALITY OF LIFE ON EARTH RESULTING FROM
LONG-TERM RESEARCH CAPABILITY ON SSF
ENSURE SAFETY AND MAXIMIZE PRODUCTIVITY OF HUMANS IN
SPACE
NON-TERRESTRIAL ENVIRONMENT REQUIRES DEVELOPMENT
OF NEW MATERIALS AND TECHNOLOGIES TRANSFERABLE TO
PRIVATE SECTOR INDUSTRIES
KNOWLEDGE GAINED ON FUNDAMENTAL PROCESSES AP-
PLICABLE TO EARTH-BASED PROCESSING AND TECHNOLOGY
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SOME STRATEGIES TO FACILITATE COMMERCIAL SPACE
o Increase private sector awareness of potential areas for
commercialization
o Continued contact with private sector companies
o Collaborative research with university researchers
o Dissemination of knowledge gained to scientific community by
publications, conferences, seminars, displays.
O Education
o Involvement of students at the intermediate and high
school and university levels
PROSPECTS FOR THE FUTURE
Commercial space ventures are expected to increase as the
database targets potential profit-making processes and products
from microgravity technology development.
0 • Spending in the area of biopharmaceuticals is increasing.
o Earth-based spending for biopharmaceuticals by the end of
this decade is projected to be in the range of $60 billion, 50
times greater than it is now.
0 Cooperative CCDS research in the above mentioned areas is
essential for maturing SSF biotechnology
0 New technologies are expected to develop and to ensure U.S.
leadership in space technology.
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